Elecon Engineering Company’s Board of Directors has approved the appointment of Mr. Pranav C. Amin as an Additional Director, designated as Non-Executive & Independent Director, for a second term of five years, effective June 22, 2026. The Board also approved the re-constitution of various committees, with updated compositions detailed in Annexure B. The meeting commenced at 5:10 p.m. and concluded at 5:25 p.m. on June 22, 2026.
Board Meeting Outcome: Director Appointment
At a Board of Directors meeting held on June 22, 2026, Elecon Engineering Company approved the appointment of Mr. Pranav C. Amin (DIN: 00245099) as an Additional Director. He will serve as a Non-Executive & Independent Director for his second term of five consecutive years, commencing June 22, 2026. This appointment is subject to the approval of the Company Members via a Special Resolution. Mr. Amin is not debarred from holding a director’s office, is not related to any existing Director, and meets the independence criteria.
Director’s Profile and Re-appointment Details
Mr. Pranav C. Amin’s first term of five years expired on May 26, 2026, and he ceased to be a Director on May 27, 2026. His reappointment is based on the recommendation of the Nomination & Remuneration Committee. He holds a degree in Economics/Industrial Management and an MBA with a focus on International Management. Currently, he is the Managing Director of Alembic Pharmaceuticals Limited.
Committee Re-constitution Approved
The Board also approved the re-constitution of the Committees of the Board of Directors, effective June 22, 2026. The updated compositions for the Audit Committee, Nomination & Remuneration Committee, and Corporate Social Responsibility Committee are detailed in Annexure B. Mr. Pranav C. Amin has been included as a Member in the Audit Committee and the Nomination & Remuneration Committee, and appointed as Chairman of the Corporate Social Responsibility Committee.
Meeting Details
The Board meeting commenced at 5:10 p.m. and concluded at 5:25 p.m. on June 22, 2026.
Source: BSE
